Insider Transactions in Q1 2026 at Aeglea Bio Therapeutics, Inc. (AGLE)

AGLE Quotes by TradingView

Insider Transaction List (Q1 2026)

Date Insider Transaction Ownership Type Shares Traded Value / Price
Jan 02 2026
Cameron Turtle Chief Executive Officer
SELL
Open market or private sale
Direct
15,000 -0.73%
$465,000 $31.55 P/Share

Track Institutional and Insider Activities on AGLE

Follow Aeglea BioTherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGLE shares.

Notify only if

Insider Trading

Get notified when an Aeglea Bio Therapeutics, Inc. insider buys or sells AGLE shares.

Notify only if

News

Receive news related to Aeglea BioTherapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AGLE